One of the most common conversations in aesthetics practice begins with a client saying something like, “My skin just changed.” Often, this observation comes suddenly. A patient who has spent years caring for her skin begins to notice that it feels thinner, less resilient, and less responsive to treatments that once worked reliably. Fine lines appear more easily, elasticity seems diminished, and the overall texture of her skin simply feels different.
While environmental factors such as ultraviolet exposure and lifestyle certainly contribute to these changes, one of the most powerful drivers is hormonal balance. Estrogen plays a critical role in maintaining the structural integrity of skin, and as estrogen levels decline during the menopausal transition, measurable changes occur in collagen, elastin, hydration, and dermal thickness.
Understanding the hormone-skin connection helps explain many of the changes seen every day in aesthetics practice. Many of the changes treated clinically are not simply cosmetic; they reflect deeper physiological shifts occurring within the extracellular matrix of skin.
THE ARCHITECTURE OF SKIN
The dermis, the structural layer of skin, is composed primarily of collagen and elastin fibers embedded within a complex extracellular matrix. Collagen is the dominant structural protein of the dermis and accounts for much of its strength and density. Produced by dermal fibroblasts, collagen fibers run parallel to the surface of skin and provide the firmness and structural support associated with youthful skin.
Elastin fibers form a finer, more delicate network interwoven among these collagen bundles. While collagen provides strength, elastin allows skin to stretch and recoil, contributing to its flexibility and resilience.
The dermis also contains glycosaminoglycans (GAGs), including hyaluronic acid, which bind water and help maintain hydration and dermal turgor. Blood vessels, immune cells, and nerve fibers further contribute to the dynamic biology of this tissue.
Estrogen influences many aspects of this system. Estrogen receptors are widely distributed throughout skin, including within dermal fibroblasts, keratinocytes, and vascular endothelial cells. Through these receptors, estrogen helps regulate collagen metabolism, extracellular matrix organization, vascularization, and skin hydration. When estrogen levels decline, this regulatory influence begins to diminish.
WHERE HORMONAL AGING BEGINS
Among the most well-documented consequences of menopause on skin is the decline in dermal collagen. Research suggests that women may lose up to 30% of skin collagen within the first five years after menopause, followed by a continued annual decline thereafter. Over longer periods, collagen content decreases by approximately 2% per year, contributing to dermal thinning, wrinkling, and loss of structural support.
Collagen loss alters the mechanical properties of skin. As collagen fibers become reduced and disorganized, the dermis becomes less capable of resisting mechanical forces. Skin gradually becomes thinner, less firm, and more prone to visible folding and laxity. From a clinical standpoint, this change has important implications. Many aesthetics treatments, including energy-based devices, microneedling, and biostimulatory injectables, depend on skin’s ability to stimulate collagen remodeling.
When the hormonal environment changes, fibroblast activity and collagen metabolism may change as well. The biological foundation supporting many aesthetics treatments is evolving during the menopausal transition.
Several studies have demonstrated that hormone replacement therapy can influence collagen content in postmenopausal skin. Increases in dermal collagen have been observed in women receiving systemic or topical estrogen therapy, suggesting that estrogen helps maintain the balance between collagen synthesis and degradation within the dermis.
While further research is needed to fully understand the dermatologic implications of hormone therapy, these findings reinforce the idea that estrogen plays a key role in connective tissue maintenance.
A MORE COMPLICATED PICTURE
While collagen provides structural strength, elastin is responsible for skin’s flexibility and recoil. Elastin fibers allow skin to stretch and return to its original shape, contributing to the resilience that characterizes youthful skin.
Unlike collagen, elastin turnover is extremely limited. Much of the elastin present in adult skin is produced early in life and persists for decades. As a result, damage to elastic fibers accumulates gradually over time and is difficult for the body to repair.
The relationship between estrogen and elastin is somewhat more complex than that observed with collagen. While it is well established that estrogen deficiency following menopause leads to a measurable decline in skin elasticity, the data surrounding elastin content itself is less consistent. Some studies suggest reductions in elastin levels, while others indicate that the primary change lies in fragmentation and disorganization of existing elastic fibers rather than a true loss of elastin quantity. What is more consistently observed is the functional consequence. Menopause produces a progressive increase in skin extensibility alongside a reduction in elastic recoil, leaving skin more fragile, lax, and prone to the crepey texture frequently reported by patients in midlife.
Hormonal signaling appears to play an important regulatory role in this process. Estrogen receptors are expressed in dermal fibroblasts and other skin cells, allowing estrogen to influence extracellular matrix metabolism and the organization of elastic fibers. Experimental studies suggest that estrogen may help preserve elastic fiber architecture and regulate enzymes involved in elastin degradation and remodeling.
Clinical studies also demonstrate that estrogen therapy following menopause can improve skin elasticity. In one study, Sumino et al. reported a 5.2% increase in skin elasticity after twelve months of hormone replacement therapy in postmenopausal women. These effects appear to extend beyond skin and have been observed in other connective tissues throughout the body, suggesting a broader role for estrogen in connective tissue maintenance. Importantly, the improvements in elasticity observed with hormone therapy are likely multifactorial. While elastin may play a role, the literature more consistently demonstrates estrogen’s influence on collagen content, dermal thickness, vascularization, and overall extracellular matrix quality. Together, these changes contribute to the improved mechanical properties of skin seen with estrogen replacement.
NETWORK DOWN
Estrogen also influences skin hydration and skin’s ability to repair itself, both of which are closely tied to the integrity of the extracellular matrix. Through its effects on dermal fibroblasts, estrogen supports the production of glycosaminoglycans, such as hyaluronic acid, helping the dermis retain water and maintain tissue turgor. As estrogen levels decline, reductions in dermal hydration can further compromise collagen and elastin organization, contributing to the thinner, less resilient quality often seen in aging skin.
Estrogen also plays a role in wound healing through its influence on collagen synthesis, angiogenesis, and inflammatory signaling. When hormonal signaling diminishes, skin’s ability to repair and remodel connective tissue becomes less efficient, reinforcing the structural changes occurring within the collagen and elastin network.
A BROADER PERSPECTIVE
For aesthetics practitioners, the relationship between hormones and skin biology raises an important consideration: Many of the changes professionals treat cosmetically originate from deeper physiologic shifts.
Wrinkles, laxity, and dermal thinning are not simply surface concerns. They are the visible manifestations of structural changes occurring within the collagen and elastin framework of skin. Recognizing the influence of hormonal changes allows practitioners to approach skin aging with a broader perspective. While aesthetics treatments remain powerful tools for improving skin quality, understanding the biological drivers of these changes can help guide treatment planning and patient expectations.
As women spend an increasingly large portion of their lives in the postmenopausal period, hormonal influences on skin health will become even more relevant. It is imperative that providers taking care of women develop a deeper understanding of menopause and the physiological effects it can have on nearly every aspect of a woman’s life.
References
- Brincat M, et al. “Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy.” Obstet Gynecol. 1987;70:123–127.
- Sumino H, Ichikawa S, Abe M, Endo Y, Ishikawa O, Kurabayashi M. “Effects of aging, menopause, and hormone replacement therapy on forearm skin elasticity in women.” J Am Geriatr Soc. 2004;52(6):945–949. doi:10.1111/j.1532-5415.2004.52262.x
- Brincat MP, Baron YM, Galea R. “Estrogens and the skin.” Climacteric. 2005;8(2):110–123. doi:10.1080/13697130500118100
- Brincat MP. “Hormone replacement therapy and the skin.” Maturitas. 2000;35(2):107–117. doi:10.1016/S0378-5122(00)00097-9
Jennifer Fleming, founder of The Alchemy Clinic, is an advanced practice nurse specializing in aesthetic and wellness medicine. As the only nurse practitioner in New Hampshire to hold the Certified Aesthetic Nurse Specialist (CANS) credential, she brings exceptional medical expertise and precision to her work. Fleming combines evidence-based practice with an artistic touch to achieve natural, confident results for her patients. She is especially passionate about educating others on the role of menopause in women’s health and beauty decisions – helping both practitioners and patients understand its long-term effects and the importance of preparation well before it begins.
No comments yet. Be the first to comment!
0 Comments